Dr. Seth Michaels Pollack, MD

Dr. Pollack practices at Northwestern Medical Group in Chicago, Illinois.

Dr. Pollack's NPI, 1528234143, was assigned on May 3, 2008. Dr. Pollack graduated from George Washington University School of Medicine in 2005. Dr. Pollack holds Illinois license 036154157.

Dr. Pollack's primary practice is Northwestern Medical Group, at 675 N St Clair St, Chicago, IL 60611 in Cook County. The practice phone is (312) 695-0646.

Dr. Pollack's primary practice is Northwestern Medical Group in Chicago, Illinois. Dr. Pollack is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Pollack to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pollack practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Pollack's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Pollack's licenses on file in 2 states: Illinois and Washington.

CMS data shows 22,770 Medicare services from Dr. Pollack across 26 procedure codes in 2024, for 225 Medicare patients. Medicare paid $444,707 for them. Every service was in an office.

CMS counts 225 Medicare patients who saw Dr. Pollack in 2024. The largest group is 65 to 74, with 107 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 15% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pollack's median patient age at 64, with 52% women.

In 2024, Dr. Pollack wrote 61 Medicare Part D claims for 25 patients. 72% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $21,714 in total drug cost. In 2016, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Pollack for performance year 2024, reported through an alternative payment model (APM). Dr. Pollack accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pollack as offering telehealth.

Dmand AI links Dr. Pollack to 2 clinical trials. Conditions studied include Headache, Sarcoma and Migraine Disorders. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Pollack that name 2 trials.

CMS Open Payments shows 170 general payments to Dr. Pollack from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Deciphera Pharmaceuticals Inc. paid the most, $57,253. It also lists 2 research payments totaling $1,430 in 2016, naming 2 clinical trials.

Dr. Pollack graduated from George Washington University School of Medicine in 2005.